Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 75Carcinoma, Non-Small-Cell Lung 68Multiple Myeloma 55Prostatic Neoplasms 54Leukemia, Myeloid, Acute 44Colorectal Neoplasms 44Neoplasms 40Ovarian Neoplasms 36Lymphoma 33Melanoma 31Neoplasm Metastasis 30Lymphoma, Non-Hodgkin 30Sarcoma 29Lung Neoplasms 28Endometrial Neoplasms 27Squamous Cell Carcinoma of Head and Neck 26Recurrence 25Pancreatic Neoplasms 25Carcinoma, Hepatocellular 25Glioma 23Leukemia, Lymphocytic, Chronic, B-Cell 22Hodgkin Disease 22Urinary Bladder Neoplasms 21Lymphoma, Large B-Cell, Diffuse 21Head and Neck Neoplasms 21Carcinoma, Renal Cell 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Myelodysplastic Syndromes 20Brain Neoplasms 18Hematologic Neoplasms 17

Interventions

Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Amyotrophic Lateral Sclerosis × 30 days × Clear all
NCT07002034 2026-06-03

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Reunion Neuroscience Inc

Phase 2 Recruiting
100 enrolled

Adjustment Disorders, Amyotrophic Lateral Sclerosis, Anxiety Disorders, Depression, Multiple Sclerosis, Neoplasms, Idiopathic Pulmonary Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡